Try "researchers"
HomePsychedelicsPsilocybin Benefits & Risks
PsychedelicsResources

Psilocybin Benefits & Risks

Sheba Karamat
By Sheba Karamat
In the episode, Andrew Huberman discusses what psilocybin is (chemically) and how it works at the cellular and neural circuit level to trigger neuroplasticity, which is our brain’s ability to rewire itself in ways that lead to long-lasting shifts in our emotional, cognitive and behavioural patterns and abilities. He discusses the emerging clinical trial evidence for the use of psilocybin in the treatment of depression, addictions, and other psychiatric challenges. He explains the typical duration and phases of a psilocybin journey, the different categories of dosages often used, and he explains the importance of set, setting, and support when using psychedelics. Huberman explains which groups of people place themselves at great risk by taking psilocybin as well as groups that could benefit, and I highlight the rapidly changing legal and medical landscape around psilocybin. This episode is a thorough exploration of psilocybin from the scientific and clinical literature perspective and ought to be of interest to anyone curious about psilocybin, mental health, neuroplasticity and/or psychedelics more generally.
Previous article
UC San Diego Launches Groundbreaking DMT Research Initiative
Next article
Charlotte Nichols: Turning the tide on psilocybin and mental health
Sheba Karamat
Sheba Karamat
RELATED ARTICLES

Related Articles

Load more

The Natural Halo reports on the latest industry news, research and thought leadership on cannabis, psilocybin, ibogaine and other psychedelic substances, and the reported benefits of using natural medicines. The growing science and evidence-based research highlights the therapeutic potential of cannabis and psychoactive products to treat severe depression, PTSD, drug dependency, end-of-life care and various other disorders and addictions. As many countries begin legalising the use of cannabis and psychoactive treatments, we are driving the agenda for safe cannabis and psychedelic therapies to become regulated, legalised and widely available treatments accepted fairly in society.

Contact

© Newspaper WordPress Theme by TagDiv